期刊文献+

乳腺干细胞的信号传导通路与乳腺癌 被引量:2

Correlating signal transduction pathway of mammary epithelial stem cells to breast cancer
下载PDF
导出
摘要 乳腺干细胞是成体干细胞的一种,具有多种分化和自我更新能力,乳腺干细胞的研究为乳腺再造及乳腺癌防治提供了理论依据。在正常情况下,乳腺干细胞的分化、更新能力受到信号转导通路和激素的严格调控,一旦这种机制被破坏或调控异常,细胞就会异常分化,无限制的生长、繁殖,形成乳腺癌干细胞,并发生肿瘤。乳腺干细胞增殖分化的信号转导通路Wnt、Wnt/β-catenin、Notch、Hedgehog是多种类型乳腺癌的发病基础。更好地理解乳腺干细胞的信号转导通路及调控机制,了解其自我更新的关键分子,对于设计更为有效的根除肿瘤起始细胞和乳腺癌干细胞的治疗方法至关重要。 Mammary epithelial stem cells, a kind of adult stem cells, possess the potential of multiple differentiation and self-renewal. Studies on mammary epithelial stem cells provide theoretical foundation for mammary gland reconstruction and for preventing and treating breast cancer. Generally, differentiation and renewal of mammary epithelial stem cells are strictly regulated by signal transduction pathway and hormone. Once this mechanism is destroyed or abnormally regulated, cells can abnormally differentiate, unconditionally grow, proliferate, and resulting in mammary epithelial stem cells and tumor. Signal transduction pathway of mammary epithelial stem cell proliferation and differentiation including Wnt, Wnt/β-catenin, Notch and Hedgehog is associated with the onset of breast cancer. To understand the signal transduction pathway, regulatory mechanism and key molecule of self-renewal of mammary epithelial stem cells are crucial for designing an effective method of eradicating tumor initiator cells and mammary epithelial stem cells.
作者 朱晓东
出处 《中国组织工程研究与临床康复》 CAS CSCD 北大核心 2008年第21期4151-4154,共4页 Journal of Clinical Rehabilitative Tissue Engineering Research
  • 相关文献

参考文献29

二级参考文献139

  • 1张燕军,任军,贾军,黄若宇,陈衍,张红梅.2周期大剂量化疗联合自体外周血干细胞移植治疗转移性乳腺癌的临床疗效观察[J].实用癌症杂志,2005,20(1):81-83. 被引量:5
  • 2[1]Gussoni E, Soneoka Y, Strickland CD, et al. Dystrophin expression in the mdx mouse restored by stem cell transplantation. Nature, 1999, 401:390~394.
  • 3[2]Zhou S, Schuetz JD, Bunting K D, et al. The ABC transporter ABCG2/Bcrp1 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat Med, 2001, 7:1028~10334.
  • 4[3]Scharenberg CW, Harkey MA, Torok-storb B. The ABCG2 transporter is an efficient Hochst 33342 efflux pump and is preferentially expressed by immature human hematopoietic progenitors. Blood, 2002, 99:507~512.
  • 5[4]Kim M, Turqnuist H, Jackson J, et al. The multidrug resistance transporter ABCG2(breast cancer resistance protein 1) effluxes Hochst 33342 and is overexpressed in hematopoietic stem cells. Clin Cancer Res, 2002, 8:22~28.
  • 6[5]Bunting KD. ABC transporters as phenotype markers and functional regulators of stem cells. Stem Cells, 2002, 20:11~20.
  • 7[6]Terskikh AV, Easterday MC, Li L, et al. From hematopoiesis to neuropoiesis: evidence of overlapping genetic programs. Proc Natl Acad Sci USA, 2001, 98:7034~7939.
  • 8[7]Geschwind DH, Ou J, Easterday MC, et al. A geneticed analysis of neural progenitor differentiation. Neuron, 2001, 29:32~339.
  • 9[8]Good JR, Kuspa A. Evidence that a cell-type-specific efflux pump regulates cell differentiation in Dictyostelium. Dev Biol, 2000, 220:53~61.
  • 10[9]Robbiani DR. The leukotriene C4 transporter MRP1 regulates CCL19(MIP-3B, ELC)-dependent mobilization of dendritic cells to lymph nodes. Cells, 2000, 103:757~768.

共引文献35

同被引文献71

  • 1邵志敏,沈镇宙.21世纪乳腺癌治疗的展望[J].中国癌症杂志,2005,15(5):405-407. 被引量:29
  • 2Reya T, Morrison SJ, Clarke MF, et al. Stem cells, cancer, and cancerstem cells [J]. Nature,2001,414:105-111.
  • 3Ponti D, Costa A, Zaffaroni N, et al. Isolation and In vitro propagationof tumorigenic breast cancer cells with stem/ progenitor cellproperties [J]. Cancer Res,2005,65:5505-5511.
  • 4Zhang M, Rosen JM. Stem cells in the etiology and treatment of cancer[J]. Curr Opin Genet Dev,2006,16(1):60-64.
  • 5Dontu G,Al-Hajj M, Abdallah WM, et al. Stem cells in normal breastdevelopment and breast cancer [J]. Cell Prolif,2003,36 (Suppl 1):59-72.
  • 6Sheridan C, Kishimoto H, Fuchs RK, et al. CD44+/CD24- breastcancer cells exhibit enhanced invasive properties: an early stepnecessary for metastasis [J]. Breast Cancer Res,2006,8(5):R59.
  • 7Phillips TM, McBride WH, Pajonk F, The response ofCD24-/low/CD44+ breast cancer-initiating cells to radiation[J], J NatlCancer Inst,2006,98(24):1777-1785.
  • 8Balic M, Lin H, Young L, et al. Most early disseminated cancer cellsdetected in bone marrow of breast cancer patients have a putativebreast cancer stem cell phenotype [J]. Clin Cancer Res,2006,12(19):5615-5621.
  • 9Liu R,Wang X,Chen GY, et al. The prognostic role of a genesignature from tumorigenic breast-cancer cells [J]. N Engl J Med,2007,356(3):217-226.
  • 10Alvi AJ, Clayton H, Joshi C, et al. Functional and molecularcharacterization of mammary side population cells [J], Breast CancerRes,2003,5:Rl-R8.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部